Faraday Pharmaceuticals, Inc.
Clinical trials sponsored by Faraday Pharmaceuticals, Inc., explained in plain language.
-
Breakthrough heart attack drug shows promise in major trial
Disease control CompletedThis large study tested whether an intravenous drug called FDY-5301 could reduce deaths and heart failure in people who had just suffered a major heart attack (anterior STEMI). Over 2,300 participants received either the drug or a placebo along with standard emergency heart proce…
Phase: PHASE3 • Sponsor: Faraday Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Experimental injection tested to protect hearts during emergency treatment
Disease control CompletedThis study tested whether a single intravenous injection of an experimental drug called FDY-5301 could reduce the amount of permanent damage to the heart muscle during emergency treatment for a major heart attack (STEMI). About 120 patients undergoing standard artery-clearing pro…
Phase: PHASE2 • Sponsor: Faraday Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC